Skip to main content

Advertisement

Table 2 Somatic morbidity of EOCSs in the "good" and the "poor" SRH groups.

From: Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors

Variables Good SRH
(N = 89)
Poor SRH
(N = 95)
P ESa
  N (%) N (%)   
Infarction, angina, stroke 16 (18) 23 (24) .35  
Hypertension > 140/90     
Treated and untreated 31 (44) 31 (42) .83  
On antihypertensive medication 13 (15) 19 (20) .34  
Diabetes 1 (1) 4 (4) .20  
BMI > 28 21 (25) 24 (27) .74  
Hyperthyroidism/hypothyroidism 11 (12) 13 (14) .79  
Musculo-skeletal diseases 33 (37) 44 (46) .20  
Aches and pain > 3 months/last year 44 (49) 64 (67) .01 .40
EORTC somatic complaints     
   Nausea 1 (1) 17 (22) < .001 .77
   Pain 11 (19) 67 (81) < .001 1.02
   Dyspnoea 21 (23) 49 (52) < .001 .93
   Insomnia 37 (42) 75 (79) < .001 .60
   Lack of appetite 5 (6) 33 (35) < .001 .77
   Constipation 26 (29) 50 (53) .002 .43
   Diarrhoea 25 (28) 42 (45) .022 .36
Physical impairment 7 (8) 46 (52) < .001 1.10
Mental impairment 4 (5) 22 (25) < .001 .70
Physical activity    .55  
   Minimal exercise 23 (26) 20 (22)   
   Moderate or more exercises 66 (74) 74 (78)   
Medication last year     
   Daily use of medication 57 (64) 84 (91) < .001 .46
   Use of analgetics 6 (7) 35 (37) < .001 .77
   Use of psychotropics 13 (15) 47 (50) < .001 .78
  1. a Effect size.